Beta
P-glycoprotein substrates
medication Under reviewP-glycoprotein substrates are a diverse group of compounds, including many drugs and xenobiotics, that are recognized and transported by P-glycoprotein (P-gp), a transmembrane ATP-binding cassette transporter encoded by the ABCB1 gene in humans. P-gp functions as an efflux pump, actively expelling these substrates from cells using energy from ATP hydrolysis. It is highly expressed in barrier tissues such as the intestine, liver, kidney, blood-brain barrier, testis, and placenta, where it limits the absorption, distribution, and penetration of substrates into protected compartments like the brain and fetus. Substrates vary widely in structure, encompassing polar and non-polar molecules, linear and hydrophobic compounds, and those with molecular weights from 250 to 4000 Da, allowing P-gp to handle an extensive range of pharmacological agents. The mechanism involves substrates binding to a large, promiscuous pocket within P-gp's transmembrane domains, lined by aromatic amino acids, which induces conformational changes that open the pump to the extracellular side for efflux. This process establishes physiological barriers, detoxifies xenobiotics, and contributes to drug resistance in certain contexts. While not a supplement itself, understanding P-gp substrates is crucial for optimizing bioavailability and therapeutic efficacy of oral medications in healthy individuals, as P-gp activity influences systemic exposure and tissue distribution.
Research summary
Scientific evidence on P-glycoprotein substrates primarily derives from in vitro cellular assays and structural studies using human P-gp-expressing models, which reliably predict in vivo efflux behavior. These models demonstrate consistent substrate identification across human and animal systems, with good correlation to brain penetration in mouse models, supporting the relevance of P-gp in human pharmacokinetics. However, direct clinical studies in healthy human subjects are scarce, limiting consensus on specific health applications or benefits beyond pharmacokinetic modulation. Research consensus highlights P-gp's role in drug transport and barrier function, with molecular dynamics simulations confirming substrate-induced conformational dynamics essential for efflux. No human trials in healthy subjects establish benefits like enhanced nutrient absorption or performance improvements, as focus remains on drug development and resistance mechanisms.
No side effects tracked yet
No side effects have been reported by studies or users for this habit yet.
Research
No studies found yet. Request research to discover relevant studies.
Community updates
No updates yet for this supplement.
Be the first to share your experience!